Your browser doesn't support javascript.
loading
Patch Testing With Methylchloroisothiazolinone/Methylisothiazolinone Using a New Diagnostic Mix-A Multicenter Study From the International Contact Dermatitis Research Group.
Isaksson, Marléne; Andersen, Klaus E; Elsner, Peter; Goh, Chee-Leok; Gonçalo, Margarida; Goossens, An; Hadzavdic, Suzana Ljubojevic; Pratt, Melanie; Puangpet, Pailin; Sasseville, Denis; Verma, Kaushal; Bruze, Magnus.
Affiliation
  • Isaksson M; From the Department of Occupational and Environmental Dermatology, Skåne University Hospital, Lund University, Malmö, Sweden.
  • Andersen KE; Dermatovenerology and Allergy Centre, Odense University Hospital, University of Southern Denmark.
  • Elsner P; Department of Dermatology, Jena University Hospital, Germany.
  • Goh CL; National Skin Centre, Singapore.
  • Gonçalo M; Department of Dermatology, University Hospital and Faculty of Medicine, University of Coimbra, Portugal.
  • Goossens A; Department of Dermatology, University Hospital KU Leuven, Belgium.
  • Hadzavdic SL; Department of Dermatology and Venereology, University Hospital Centre Zagreb, University of Zagreb School of Medicine, Croatia.
  • Pratt M; University of Ottawa, The Ottawa Hospital, Ontario, Canada.
  • Puangpet P; Institute of Dermatology, Bangkok, Thailand.
  • Sasseville D; Division of Dermatology, McGill University Health Centre, Montreal General Hospital, Québec, Canada.
  • Verma K; Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi.
  • Bruze M; From the Department of Occupational and Environmental Dermatology, Skåne University Hospital, Lund University, Malmö, Sweden.
Dermatitis ; 32(4): 220-224, 2021.
Article in En | MEDLINE | ID: mdl-33405484
ABSTRACT

BACKGROUND:

In the early 1980s, a preservative containing a mixture of methylchloroisothiazolinone (MCI) and methylisothiazolinone (MI) in a ratio of 31 was introduced. This mixture (mix) has been patch tested at 100 ppm (0.01%) worldwide and at 200 ppm (0.02%) in Sweden since 1986 and also in the European baseline series since 2014.

OBJECTIVE:

A new aqueous mix of MCI 0.015% and MI 0.2% was compared with patch testing with the 2 aqueous baseline preparations of MCI/MI 0.02% and MI 0.2%.

METHODS:

Four thousand three hundred ninety-seven patients with dermatitis in 12 International Contact Dermatitis Research Group dermatology departments from 3 continents were patch tested simultaneously with the 3 preparations.

RESULTS:

The frequency of positive patch tests to the allergens varied between 0% and 26.7% in the 12 test centers. The new mixture MCI/MI 0.215% in aqua (aq) detected significantly more patients with MCI/MI allergy than both MCI/MI 0.02% aq (P < 0.001) and MI 0.2% aq (P < 0.001) alone and combined.

CONCLUSIONS:

The results favor replacing the preparations MCI/MI 0.02% aq and MI 0.2% aq with the mixture MCI/MI 0.215% aq in the International Contact Dermatitis Research Group baseline series.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thiazoles / Patch Tests / Dermatitis, Contact Type of study: Clinical_trials / Diagnostic_studies Limits: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Infant / Male Country/Region as subject: Europa Language: En Journal: Dermatitis Journal subject: DERMATOLOGIA Year: 2021 Document type: Article Affiliation country: Suecia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thiazoles / Patch Tests / Dermatitis, Contact Type of study: Clinical_trials / Diagnostic_studies Limits: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Infant / Male Country/Region as subject: Europa Language: En Journal: Dermatitis Journal subject: DERMATOLOGIA Year: 2021 Document type: Article Affiliation country: Suecia